Tuesday, April 09, 2013
EFFICACY OF ANTEMORTEM RECTAL BIOPSIES TO DIAGNOSE AND ESTIMATE PREVALENCE
OF CHRONIC WASTING DISEASE IN FREE-RANGING COW ELK (CERVUS ELAPHUS NELSONI)
Ryan J. Monello1,6, Jenny G. Powers1, N. Thompson Hobbs2, Terry R.
Spraker3, Katherine I. O’Rourke4,5 and Margaret A. Wild1
+ Author Affiliations
1National Park Service, Biological Resource Management Division, 1201 Oak
Ridge Drive, Suite 200, Fort Collins, Colorado 80525, USA
2Natural Resource Ecology Laboratory and Graduate Degree Program in
Ecology, Colorado State University, Fort Collins, Colorado 80523, USA
3Colorado State Diagnostic Laboratory, College of Veterinary Medicine,
Colorado State University, Fort Collins, Colorado 80523, USA
4United States Department of Agriculture, Agricultural Research Service,
Animal Disease Research Unit, 3003 Animal Disease Biotechnology Facility,
Washington State University, Pullman, Washington 99164, USA
↵6 Corresponding author (email: Ryan_Monello@nps.gov)
Abstract
A reliable antemortem test is needed to understand the ecology of chronic
wasting disease (CWD) in elk (Cervus elaphus nelsoni). We measured the ability
of antemortem biopsy samples from the rectal mucosa to detect the abnormal prion
protein associated with CWD (PrPCWD), the relationship between test results from
the obex and rectal biopsies at varying stages of CWD progression, and the
prevalence of CWD in free-ranging elk from Rocky Mountain National Park,
Colorado, USA. We sampled and placed radio collars on 136 adult female elk in
the winter of 2007–08. Elk with biopsy samples found positive for PrPCWD by
immunohistochemistry (IHC) were euthanized and the obex and retropharyngeal
lymph nodes were examined with IHC. We resampled, euthanized, and necropsied 20,
25, and 34 of the remaining study elk in each of the three following winters,
respectively. Sensitivity of rectal biopsy samples increased in an asymptotic
fashion with follicle count and was maximized at 85% (95% credible limits
[CL]=60, 98) in the beginning of the study, when a greater proportion of elk
were in a detectable stage of prion infection. However, maximum sensitivity was
reduced to 72% (CL=46, 94) when we included resampled elk, which included
recently infected elk that were initially negative using rectal biopsies and
IHC. Test results were similar between rectal biopsies and the obex, but the
earliest stages of prion infection were only detected by using retropharyngeal
lymph nodes. Minimum CWD prevalence was estimated to be 9.9% (CL=5.7, 15.7)
using rectal biopsies, but this rose to 12.9% (CL=8.0, 19.1) when we included
four elk that were likely misdiagnosed at initial capture. Our results indicate
rectal biopsies can provide a useful research tool for CWD in elk populations,
but should be used with caution because they can miss individuals in early
stages of infection and underestimate prevalence. Prevalence estimates from this
population are the highest reported to date in elk and indicate that under
appropriate conditions, CWD may be able to affect the dynamics of high-density
elk populations.
Biopsy Cervus elaphus chronic wasting disease Colorado CWD elk prion rectal
mucosa
Received December 22, 2011. Accepted October 9, 2012.
© Wildlife Disease Association 2013
Friday, August 24, 2012
Diagnostic accuracy of rectal mucosa biopsy testing for chronic wasting
disease within white-tailed deer (Odocoileus virginianus) herds in North America
Tuesday, December 18, 2012
A Growing Threat How deer breeding could put public trust wildlife at risk
Sunday, February 03, 2013
Mucosal transmission and pathogenesis of chronic wasting disease in ferrets
Thursday, February 21, 2013
Game and Fish Begins Study to Evaluate Chronic Wasting Disease
Vaccine
Tuesday, April 02, 2013
IMPORTANT: Cervid Industry and State Veterinarians on Rewriting Chronic
Wasting Disease Rule
TSS
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home